These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39009522)

  • 1. [Comparison of Preparation Efficiency and Therapeutic Safety between Brand-Name and Generic Products of Pemetrexed].
    Tatsuta R; Sumimoto T; Shiraiwa K; Nakahara R; Tanaka R; Itoh H
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):637-641. PubMed ID: 39009522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
    Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly JG; Fischer MA; Kesselheim AS; Gagne JJ
    PLoS Med; 2019 Mar; 16(3):e1002763. PubMed ID: 30865626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
    Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
    Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program.
    Witt DM; Tillman DJ; Evans CM; Plotkin TV; Sadler MA
    Pharmacotherapy; 2003 Mar; 23(3):360-8. PubMed ID: 12627935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug.
    Hansen RA; Qian J; Berg RL; Linneman JG; Seoane-Vazquez E; Dutcher S; Raofi S; Page CD; Peissig PL
    Clin Pharmacol Ther; 2018 Feb; 103(2):310-317. PubMed ID: 27981563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
    Gagne JJ; Polinski JM; Jiang W; Dutcher SK; Xie J; Lii J; Fulchino LA; Kesselheim AS
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis.
    Leclerc J; Blais C; Rochette L; Hamel D; Guénette L; Poirier P
    Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 28974512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brand name versus generic warfarin: a systematic review of the literature.
    Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
    Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of generic versus brand-name antiepileptic medications.
    Gagne JJ; Kesselheim AS; Choudhry NK; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
    Epilepsy Behav; 2015 Nov; 52(Pt A):14-8. PubMed ID: 26386779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.
    Ochi N; Yamane H; Hotta K; Fujii H; Isozaki H; Honda Y; Yamagishi T; Kubo T; Tanimoto M; Kiura K; Takigawa N
    Drug Des Devel Ther; 2014; 8():2401-8. PubMed ID: 25584019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex.
    Navarro-Artieda R; Rejas-Gutiérrez J; Pérez-Paramo M; Sicras-Mainar A
    Neurologia (Engl Ed); 2018 Apr; 33(3):141-153. PubMed ID: 27321171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting patients from brand-name clozapine to generic clozapine.
    Sajbel TA; Carter GW; Wiley RB
    Ann Pharmacother; 2001 Mar; 35(3):281-4. PubMed ID: 11261523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and economic consequences in patients initiating therapy with clopidogrel brand-name vs. generic: A real-life retrospective study].
    Sicras-Mainar A; Escobar-Cervantes C; Micó-Pérez RM; Llisterri-Caro JL
    Semergen; 2020; 46(1):16-26. PubMed ID: 31345684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of generic-only drug benefits on seniors' medication use and financial burden.
    Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
    Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?
    Leclerc J; Blais C; Rochette L; Hamel D; Guénette L; Poirier P
    Drugs Aging; 2019 Aug; 36(8):759-768. PubMed ID: 31073846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brand-to-generic oxcarbazepine switch - A prospective observational study.
    Bosak M; Słowik A; Dziedzic T
    Epilepsy Res; 2019 Mar; 151():75-77. PubMed ID: 30836239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis.
    Leclerc J; Thibault M; Midiani Gonella J; Beaudoin C; Sampalis J
    Drugs; 2020 May; 80(7):697-710. PubMed ID: 32279239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.